Variant report

Variant	nsv1057975
Chromosome Location	chr20:23647482-23702005
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr20:23649147-23649450	HepG2	liver:	n/a	n/a
2	BRCA1	chr20:23649179-23649335	HepG2	liver:	n/a	n/a
3	CEBPB	chr20:23684405-23684588	HepG2	liver:	n/a	chr20:23684504-23684515 chr20:23684504-23684517 chr20:23684506-23684515 chr20:23684506-23684515 chr20:23684506-23684515 chr20:23684506-23684517 chr20:23684506-23684515
4	CEBPB	chr20:23687909-23688202	HepG2	liver:	n/a	chr20:23688059-23688070
5	CEBPB	chr20:23687946-23688194	A549	lung:	n/a	chr20:23688059-23688070
6	CEBPB	chr20:23687994-23688164	IMR90	lung:	n/a	chr20:23688059-23688070
7	CEBPB	chr20:23655411-23655454	HepG2	liver:	n/a	n/a
8	CEBPB	chr20:23684500-23684595	A549	lung:	n/a	chr20:23684504-23684515 chr20:23684504-23684517 chr20:23684506-23684515 chr20:23684506-23684515 chr20:23684506-23684515 chr20:23684506-23684517 chr20:23684506-23684515
9	CHD1	chr20:23648812-23649497	IMR90	lung:	n/a	n/a
10	CHD2	chr20:23649288-23649303	GM12878	blood:	n/a	n/a
11	CHD2	chr20:23649131-23649258	HepG2	liver:	n/a	n/a
12	CTCF	chr20:23649041-23649632	K562	blood:	n/a	chr20:23649448-23649464 chr20:23649447-23649465 chr20:23649201-23649222 chr20:23649449-23649470 chr20:23649199-23649217 chr20:23649200-23649216
13	CTCF	chr20:23677536-23677581	Kidney_OC	kidney:	n/a	n/a
14	CTCF	chr20:23667735-23667994	K562	blood:	n/a	n/a
15	CTCF	chr20:23649140-23649290	NHLF	lung:	n/a	chr20:23649201-23649222 chr20:23649199-23649217 chr20:23649200-23649216
16	CTCF	chr20:23648931-23649670	HCT-116	colon:	n/a	chr20:23649448-23649464 chr20:23649447-23649465 chr20:23649201-23649222 chr20:23649449-23649470 chr20:23649199-23649217 chr20:23649200-23649216
17	CTCF	chr20:23648480-23648630	GM12869	blood:	n/a	n/a
18	CTCF	chr20:23649120-23649270	GM12875	blood:	n/a	chr20:23649201-23649222 chr20:23649199-23649217 chr20:23649200-23649216
19	CTCF	chr20:23648527-23649805	A549	lung:	n/a	chr20:23649448-23649464 chr20:23649447-23649465 chr20:23649201-23649222 chr20:23649449-23649470 chr20:23649199-23649217 chr20:23649200-23649216
20	CTCF	chr20:23649120-23649270	HPAF	blood vessel:	n/a	chr20:23649201-23649222 chr20:23649199-23649217 chr20:23649200-23649216
21	CTCF	chr20:23649140-23649290	HAc	cerebellar:	n/a	chr20:23649201-23649222 chr20:23649199-23649217 chr20:23649200-23649216
22	CTCF	chr20:23649180-23649330	GM06990	blood:	n/a	chr20:23649201-23649222 chr20:23649199-23649217 chr20:23649200-23649216
23	CTCF	chr20:23649520-23649670	HRPEpiC	eye:	n/a	n/a
24	CTCF	chr20:23649467-23649556	GM12878	blood:	n/a	n/a
25	CTCF	chr20:23648680-23648830	HAc	cerebellar:	n/a	n/a
26	CTCF	chr20:23649120-23649270	AG09309	skin:	n/a	chr20:23649201-23649222 chr20:23649199-23649217 chr20:23649200-23649216
27	CTCF	chr20:23649140-23649290	HA-sp	spinal cord:	n/a	chr20:23649201-23649222 chr20:23649199-23649217 chr20:23649200-23649216
28	CTCF	chr20:23649078-23649378	Pancreas_OC	pancreas:	n/a	chr20:23649201-23649222 chr20:23649199-23649217 chr20:23649200-23649216
29	CTCF	chr20:23649160-23649310	HepG2	liver:	n/a	chr20:23649201-23649222 chr20:23649199-23649217 chr20:23649200-23649216
30	CTCF	chr20:23649566-23649570	HepG2	liver:	n/a	n/a
31	CTCF	chr20:23649520-23649670	GM12871	blood:	n/a	n/a
32	CTCF	chr20:23648810-23649785	HepG2	liver:	n/a	chr20:23649448-23649464 chr20:23649447-23649465 chr20:23649201-23649222 chr20:23649449-23649470 chr20:23649199-23649217 chr20:23649200-23649216
33	CTCF	chr20:23649120-23649270	MCF-7	breast:	n/a	chr20:23649201-23649222 chr20:23649199-23649217 chr20:23649200-23649216
34	CTCF	chr20:23649066-23649553	ProgFib	skin:	n/a	chr20:23649448-23649464 chr20:23649447-23649465 chr20:23649201-23649222 chr20:23649449-23649470 chr20:23649199-23649217 chr20:23649200-23649216
35	CTCF	chr20:23649354-23649576	GM13977	blood:	n/a	chr20:23649448-23649464 chr20:23649447-23649465 chr20:23649449-23649470
36	CTCF	chr20:23667766-23667943	GM13977	blood:	n/a	n/a
37	CTCF	chr20:23648400-23648550	HEK293	kidney:	n/a	n/a
38	CTCF	chr20:23649088-23649655	A549	lung:	n/a	chr20:23649448-23649464 chr20:23649447-23649465 chr20:23649201-23649222 chr20:23649449-23649470 chr20:23649199-23649217 chr20:23649200-23649216
39	CTCF	chr20:23649120-23649270	AG09319	gingival:	n/a	chr20:23649201-23649222 chr20:23649199-23649217 chr20:23649200-23649216
40	CTCF	chr20:23649120-23649270	HFF-Myc	foreskin:	n/a	chr20:23649201-23649222 chr20:23649199-23649217 chr20:23649200-23649216
41	CTCF	chr20:23649040-23649190	HAc	cerebellar:	n/a	n/a
42	CTCF	chr20:23654022-23654099	LNCaP	prostate:	n/a	n/a
43	CTCF	chr20:23649140-23649290	HL-60	blood:	n/a	chr20:23649201-23649222 chr20:23649199-23649217 chr20:23649200-23649216
44	CTCF	chr20:23649080-23649230	Hela-S3	cervix:	n/a	chr20:23649201-23649222 chr20:23649199-23649217 chr20:23649200-23649216
45	CTCF	chr20:23650218-23650382	GM19239	blood:	n/a	n/a
46	CTCF	chr20:23649404-23649517	GM19239	blood:	n/a	chr20:23649448-23649464 chr20:23649447-23649465 chr20:23649449-23649470
47	CTCF	chr20:23671663-23671721	Spleen_OC	spleen:	n/a	n/a
48	CTCF	chr20:23649063-23649585	LNCaP	prostate:	n/a	chr20:23649448-23649464 chr20:23649447-23649465 chr20:23649201-23649222 chr20:23649449-23649470 chr20:23649199-23649217 chr20:23649200-23649216
49	CTCF	chr20:23649140-23649290	AG04450	lung:	n/a	chr20:23649201-23649222 chr20:23649199-23649217 chr20:23649200-23649216
50	CTCF	chr20:23649061-23649589	MCF-7	breast:	n/a	chr20:23649448-23649464 chr20:23649447-23649465 chr20:23649201-23649222 chr20:23649449-23649470 chr20:23649199-23649217 chr20:23649200-23649216

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr20:23671108-23671158	HNPCEpiC	eye:	n/a
2	chr20:23666505-23666555	HRPEpiC	eye:	n/a
3	chr20:23670089-23670139	AG09319	gingival:	n/a
4	chr20:23670089-23670139	GM12891	blood:	n/a
5	chr20:23669470-23669520	AG09309	skin:	n/a
6	chr20:23669470-23669520	H1-hESC	embryonic stem cell:	embryo
7	chr20:23669241-23669291	LNCaP	prostate:	n/a
8	chr20:23670089-23670139	HCPEpiC	choroid plexus:	n/a
9	chr20:23669470-23669520	MCF-7	breast:	n/a
10	chr20:23671108-23671158	NB4	blood:	n/a
11	chr20:23669241-23669291	AoSMC	blood vessel:	n/a
12	chr20:23670047-23670097	HCT-116	colon:	n/a
13	chr20:23666505-23666555	HL-60	blood:	n/a
14	chr20:23670047-23670097	PANC-1	pancreas:	n/a
15	chr20:23670047-23670097	H1-hESC	embryonic stem cell:	embryo
16	chr20:23669470-23669520	HepG2	liver:	n/a
17	chr20:23671108-23671158	ECC-1	luminal epithelium:	n/a
18	chr20:23666505-23666555	BE2_C	brain:	n/a
19	chr20:23670089-23670139	GM19239	blood:	n/a
20	chr20:23671108-23671158	Jurkat	blood:	n/a
21	chr20:23670047-23670097	ovcar-3	ovarian:	n/a
22	chr20:23671108-23671158	BJ	skin:	n/a
23	chr20:23669241-23669291	Hela-S3	cervix:	n/a
24	chr20:23669241-23669291	GM06990	blood:	n/a
25	chr20:23666505-23666555	HAEpiC	amniotic membrane:	n/a
26	chr20:23670047-23670097	AG10803	skin:	n/a
27	chr20:23669241-23669291	K562	blood:	n/a
28	chr20:23671108-23671158	HCF	heart:	n/a
29	chr20:23669470-23669520	HCPEpiC	choroid plexus:	n/a
30	chr20:23670089-23670139	ovcar-3	ovarian:	n/a
31	chr20:23670047-23670097	AG04449	skin:	fetal
32	chr20:23669241-23669291	GM12891	blood:	n/a
33	chr20:23666505-23666555	HIPEpiC	eye:	n/a
34	chr20:23669470-23669520	AoSMC	blood vessel:	n/a
35	chr20:23666505-23666555	A549	lung:	n/a
36	chr20:23669241-23669291	AG04450	lung:	fetal
37	chr20:23670047-23670097	NHDF-neo	bronchial:	n/a
38	chr20:23670089-23670139	Hela-S3	cervix:	n/a
39	chr20:23666505-23666555	HCT-116	colon:	n/a
40	chr20:23666505-23666555	GM06990	blood:	n/a
41	chr20:23669470-23669520	HCM	heart:	n/a
42	chr20:23666505-23666555	HRCEpiC	kidney:	n/a
43	chr20:23670047-23670097	AoSMC	blood vessel:	n/a
44	chr20:23670089-23670139	HCF	heart:	n/a
45	chr20:23669241-23669291	SKMC	muscle:	n/a
46	chr20:23670047-23670097	T-47D	breast:	n/a
47	chr20:23670089-23670139	T-47D	breast:	n/a
48	chr20:23670089-23670139	NHDF-neo	bronchial:	n/a
49	chr20:23671108-23671158	GM06990	blood:	n/a
50	chr20:23671108-23671158	HCPEpiC	choroid plexus:	n/a

No.	Distal block	Cell Line	Cell type
1	chr20:23648767..23649721-chr20:23779902..23780425,2	MCF-7	breast:
2	chr20:23648954..23649672-chr20:23703387..23704074,2	MCF-7	breast:
3	chr20:23648842..23649774-chr20:23870335..23871266,4	MCF-7	breast:
4	chr20:23649611..23652412-chr20:23660454..23663208,2	MCF-7	breast:
5	chr20:23649611..23652412-chr20:23660454..23663208,2	MCF-7	breast:
6	chr20:23648920..23650143-chr20:23704363..23705222,5	MCF-7	breast:
7	chr20:23649188..23649689-chr20:23762769..23763504,2	MCF-7	breast:
8	chr20:23648334..23649447-chr20:23704109..23705001,3	MCF-7	breast:
9	chr20:23648665..23649293-chr20:23837547..23838405,2	MCF-7	breast:

Variant related genes	Relation type
CST4	TF binding region
CST2P1	TF binding region
CST4	CpG island
CST2P1	CpG island

Extended variants
information (count: 2278 )
Associated
traits (count: 60 )

Variant overlapped rSNPs/rCNVs (count:2278 , 50 per page) page: 1 2 3 4 5 6 7 ... 46

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs1884861	chr20:23647482-23647483	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs546268750	chr20:23647484-23647485	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs566505019	chr20:23647493-23647494	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs538639009	chr20:23647507-23647508	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs552860758	chr20:23647531-23647532	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs569585567	chr20:23647532-23647533	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs189443419	chr20:23647536-23647537	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs181497283	chr20:23647560-23647561	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs574824787	chr20:23647570-23647571	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs184490044	chr20:23647622-23647623	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs553877410	chr20:23647667-23647668	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs577122939	chr20:23647708-23647709	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs138932442	chr20:23647716-23647717	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs564804750	chr20:23647769-23647770	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs188941002	chr20:23647781-23647782	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs543986939	chr20:23647821-23647822	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs530885267	chr20:23647824-23647825	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs561176699	chr20:23647840-23647841	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs181121836	chr20:23647912-23647913	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs186615791	chr20:23647916-23647917	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs559998666	chr20:23647926-23647927	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs145880187	chr20:23647966-23647967	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs113331859	chr20:23648007-23648008	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs138498304	chr20:23648015-23648016	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs149243859	chr20:23648016-23648017	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs2424598	chr20:23648032-23648033	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
27	rs536086731	chr20:23648068-23648069	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs111942738	chr20:23648071-23648072	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs144417764	chr20:23648075-23648076	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs367895090	chr20:23648082-23648083	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs568683839	chr20:23648122-23648123	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs147983705	chr20:23648125-23648126	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs141663060	chr20:23648198-23648199	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs576941882	chr20:23648199-23648200	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs539425630	chr20:23648226-23648227	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
36	rs190666171	chr20:23648249-23648250	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
37	rs181006612	chr20:23648270-23648271	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
38	rs11907430	chr20:23648297-23648298	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
39	rs2983609	chr20:23648318-23648319	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
40	rs554397657	chr20:23648320-23648321	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
41	rs147171536	chr20:23648329-23648330	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
42	rs6138032	chr20:23648357-23648358	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
43	rs375058620	chr20:23648362-23648363	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
44	rs532275445	chr20:23648365-23648366	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
45	rs397834905	chr20:23648372-23648373	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
46	rs552189070	chr20:23648379-23648380	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
47	rs140480308	chr20:23648382-23648383	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs532039943	chr20:23648411-23648412	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs6138033	chr20:23648442-23648443	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
50	rs548820016	chr20:23648450-23648451	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:60)

Disease	PMID	Source
Wilms tumour	21544195	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	16272173	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	19627613	CNVD
colon cancer	17210682	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	21080181	CNVD
Thyroid cancer	19087340	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Colorectal cancer	19359472	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Human rectal carcinomas	16397240	CNVD
Olfactory neuroblastoma	18408657	CNVD
Central neurocytomas	17123091	CNVD
Colorectal cancer	16272173	CNVD
Medulloblastoma	21979893	CNVD
Gastric cancer	17908304	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Colorectal cancer	21645411	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Autism	22495311	CNVD
Renal cell carcinoma	18765545	CNVD
Alagille syndrome	17576883	CNVD
Anaplastic large cell lymphoma	18179710	CNVD
Prostate cancer	18632612	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Cancer	21183584	CNVD
Myxofibrosarcoma	16751306	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Breast cancer	16608533	CNVD
Bladder cancer	21909424	CNVD
Esophageal cancer	21851588	CNVD
Breast cancer	17133270	CNVD
Thrombophilia	17576883	CNVD
Myelofibrosis	22110671	CNVD
Mental retardation	21062444	CNVD
Hepatocellular carcinoma	22174799	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Chordoma	18071362	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
small cell lung cancer	17426248	CNVD
Breast cancer	21364760	CNVD
Gastric cancer	22014070	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:189 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr20:23637200-23660000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
2	chr20:23641800-23652200	Weak transcription	Adipose Nuclei	Adipose
3	chr20:23642400-23649400	Weak transcription	Skeletal Muscle Male	skeletal muscle
4	chr20:23643800-23647800	Weak transcription	Fetal Muscle Leg	muscle
5	chr20:23644000-23648400	Weak transcription	Fetal Muscle Trunk	muscle
6	chr20:23646000-23649200	Weak transcription	HepG2	liver
7	chr20:23647000-23647600	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
8	chr20:23647000-23647600	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
9	chr20:23647000-23647600	Enhancers	Monocytes-CD14+_RO01746	blood
10	chr20:23647000-23647800	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
11	chr20:23647000-23648000	Enhancers	Primary monocytes fromperipheralblood	blood
12	chr20:23647000-23648000	Enhancers	Cortex derived primary cultured neurospheres	brain
13	chr20:23647000-23648000	Enhancers	HUVEC	blood vessel
14	chr20:23647000-23648200	Enhancers	Spleen	Spleen
15	chr20:23647000-23648800	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
16	chr20:23647200-23648000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
17	chr20:23647200-23648400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
18	chr20:23647400-23648000	Enhancers	HSMMtube	muscle
19	chr20:23647400-23648200	Enhancers	Fetal Lung	lung
20	chr20:23647600-23648600	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
21	chr20:23647800-23648200	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
22	chr20:23647800-23648200	Enhancers	Fetal Muscle Leg	muscle
23	chr20:23647800-23648200	Weak transcription	Skeletal Muscle Female	skeletal muscle
24	chr20:23648200-23648400	Weak transcription	Fetal Muscle Leg	muscle
25	chr20:23648200-23648400	Enhancers	Skeletal Muscle Female	skeletal muscle
26	chr20:23648200-23649400	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
27	chr20:23648200-23650400	Weak transcription	Spleen	Spleen
28	chr20:23648400-23648600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
29	chr20:23648400-23648600	Enhancers	Fetal Muscle Trunk	muscle
30	chr20:23648400-23648800	Enhancers	Fetal Muscle Leg	muscle
31	chr20:23648400-23649200	Weak transcription	Skeletal Muscle Female	skeletal muscle
32	chr20:23648600-23648800	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
33	chr20:23648600-23649000	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
34	chr20:23648800-23649200	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
35	chr20:23649000-23650400	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
36	chr20:23649200-23649400	Enhancers	Skeletal Muscle Female	skeletal muscle
37	chr20:23649200-23649600	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
38	chr20:23649200-23649600	Enhancers	HepG2	liver
39	chr20:23649400-23649600	Enhancers	Skeletal Muscle Male	skeletal muscle
40	chr20:23650600-23650800	Enhancers	Spleen	Spleen
41	chr20:23652200-23652800	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
42	chr20:23652200-23652800	Enhancers	Adipose Nuclei	Adipose
43	chr20:23652400-23652600	Enhancers	Skeletal Muscle Male	skeletal muscle
44	chr20:23659800-23660400	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
45	chr20:23659800-23660600	Enhancers	HMEC	breast
46	chr20:23660000-23660600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
47	chr20:23660000-23661200	Enhancers	Right Atrium	heart
48	chr20:23660200-23660600	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
49	chr20:23660400-23661000	Enhancers	Adipose Nuclei	Adipose
50	chr20:23660400-23661200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links